Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Class III β-Tubulin Expression and Benefit from Adjuvant Cisplatin/Vinorelbine Chemotherapy in Operable Non–Small Cell Lung Cancer: Analysis of NCIC JBR.10
Purpose: High class III β-tubulin (bTubIII) expression in advanced non–small cell lung cancer is known to correlate with reduced response rates and inferior survival with anti-microtubule agents.… Expand
Manifestations systmiques des infections Parvovirus B19
- P. Sève, T. Ferry, A. Charhon, A. Calvet, C. Broussolle
- Medicine
- 1 October 2004
Resume Propos. – Parvovirus B19 (PVB19) est responsable de nombreuses maladies, dont les plus frequentes sont le megalerytheme epidemique, les crises d'erythroblastopenies compliquant les hemolyses… Expand
Maladie de Kawasaki de l’adulte
Resume La maladie de Kawasaki (MK) est une vascularite multisystemique touchant principalement la peau, les muqueuses et les ganglions. Des anevrismes coronariens surviennent chez 25 % des patients,… Expand
Les carcinomes de primitif inconnu
- P. Sève, K. Stankovic, A. Charhon, C. Broussolle
- Philosophy
- 1 July 2006
Resume Propos. – Les carcinomes de primitif inconnu sont frequents, constituant 2 % de l'ensemble des cancers. Ils posent des problemes diagnostiques recurrents aux internistes. Ils soulevent des… Expand
Uveitis associated with multiple sclerosis
- J. Le Scanff, P. Sève, C. Renoux, C. Broussolle, C. Confavreux, S. Vukusic
- Medicine
- Multiple sclerosis
- 1 April 2008
Our study aimed to determine the frequency of uveitis among MS patients through the Lyon MS Database and compare the clinical spectrum and time course of MS in patients with or without uveitis.… Expand
Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials.
BACKGROUND
The IALT, JBR.10, ANITA and Cancer and Leukemia Group B 9633 trials compared adjuvant chemotherapy with observation for patients with resected non-small-cell lung cancer (R-NSCLC). Data… Expand
Class III β-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site
PurposeIn this study, we determine the prevalence and the prognostic value of the class III β-tubulin microtubule protein examined immunohistochemically, in tumors of 40 patients with carcinomas of… Expand
Déficit immunitaire commun variable avec manifestations auto-immunes : étude de neuf observations ; intérêt d’un immunophénotypage spécifique des lymphocytes B circulants chez sept patients
- M. Pavic, P. Sève, +8 authors C. Broussolle
- Medicine
- 1 February 2005
Resume Propos. – Des maladies auto-immunes (MAI) sont associees aux deficits immunitaires communs variables (DICV) dans 20 a 25 % des cas. Cette etude decrit les caracteristiques cliniques et… Expand
Apport de la consultation interniste dans le diagnostic étiologique des uvéites. Étude comparative portant sur 66 patients
- J. L. Scanff, P. Sève, L. Kodjikian, Jean-Daniel Grange, C. Broussolle
- Medicine
- 1 September 2006
Resume Propos Les uveites sont des maladies rares de causes multiples regroupant maladies infectieuses, maladies systemiques, maladies neurologiques, entites ophtalmologiques, neoplasies et causes… Expand
Beta-tubulin III expression in prostate cancer
- L. Egevad, A. Valdman, N. Wiklund, P. Sève, C. Dumontet
- Medicine
- Scandinavian journal of urology and nephrology
- 17 November 2010
Abstract Objective. Beta-tubulin isotype III is a microtubule component associated with resistance to chemotherapy and poor outcome in various cancers. This study aimed to investigate its expression… Expand